A technology company can hold several thousand patents and still struggle to name the twenty it would take to court. The rest may be close to expiry, narrowly drafted, tied to products nobody sells anymore, or impossible to prove infringement on without the other side’s source code.
Patent portfolio triage is how IP teams find those twenty. It is a structured first pass that ranks a patent portfolio by technology relevance, claim strength, market potential, evidence availability, and remaining patent life. The expensive work that follows, such as claim charting, prior art searching, and damages modelling, then goes to the patents most likely to pay for it.
This guide covers the five stages of that evaluation, the tier matrix used to act on the results, and what a patent still needs after triage before it is ready for licensing or litigation.
Key Takeaways
- Triage is the prioritisation step inside patent portfolio management. It decides where detailed analysis goes, and it comes before that analysis.
- Evidence availability is the stage teams most often skip. A patent covering a feature nobody can observe or test is a weak assertion candidate, however strong its claims read.
- Remaining patent life cuts both ways. An expired patent cannot support an injunction, but it can still recover damages for up to six years of past infringement.
- The output is a tiered list. Tier 1 patents move to claim charting and validity work; Tier 3 patents are candidates for non-renewal or sale.
- AI can rank a large portfolio in a fraction of the manual time. Claim construction, infringement evidence, and the final litigation readiness call stay with experts.
What Is Patent Portfolio Triage?
Patent portfolio triage is the systematic sorting of patents into priority tiers using technical, legal, and commercial criteria. It happens early: before a full patent portfolio analysis, before claim charts, and before any decision to license or assert.
It is narrower than patent portfolio management, which covers the whole lifecycle from filing strategy and renewal budgets through to enforcement. Our guide to managing a patent portfolio covers that wider process. Triage answers one question inside it: which of these patents deserve detailed review now.
Where Triage Pays Off
Licensing
Licensing programmes work best when built around patents that read on widely adopted products. Triage surfaces those before a campaign commits to its asset list.
Litigation Readiness
Enforcement starts with choosing the right patents. A triaged list identifies the ones with strong claim scope, technical relevance, and observable evidence of use, which are the ones worth moving into infringement analysis.
M&A and Investment Diligence
Acquirers and litigation funders care more about portfolio quality than patent count. Triage gives them a defensible view of where the value sits. For the wider process, see our guide to IP due diligence and AI-driven patent portfolio analysis.
Maintenance Cost
Renewal fees across several jurisdictions add up quickly. WIPO’s guidance on managing an IP portfolio recommends reviewing the portfolio regularly and stopping payment on assets no longer relevant to the business or to anyone else. Triage supplies the evidence for those calls.
The Five Stages of Patent Portfolio Evaluation
Methods differ between organisations, but most triage workflows score each patent against the five criteria shown in Figure 1.
Stage 1: Technology Relevance
The first screen asks whether the patent covers technology in use today, and whether it lines up with what likely licensees or defendants actually sell. Patents in areas such as wireless connectivity, video and audio codecs, AI, cloud infrastructure, and semiconductor packaging tend to rank higher because more products practise them.
Stage 2: Claim Strength
Patent strength analysis looks at the independent claims: how broad they are, how clearly they are written, and how easily a competitor could design around them. Prosecution history counts too, because amendments made to get past prior art can narrow what the claims cover in practice.
Breadth alone can mislead. A broad claim exposed to prior art is often worth less than a narrow one that maps precisely onto an industry standard.
Stage 3: Market Potential
Commercial value follows the products. A patent covering a feature in a high-volume consumer device carries more licensing and damages value than one covering a niche industrial process. Revenue from target products, market adoption, and the number of potential licensees all feed this score.
Stage 4: Evidence Availability
This is the stage teams skip most often, and it frequently decides whether a patent can be asserted at all. Patent infringement analysis has to show that the accused product practises every element of a claim. When the patented feature runs inside proprietary firmware, a server backend, or a chip, that may not be possible from public information.
Evidence can come from public documentation, standards specifications, product testing, reverse engineering, or, once a case is filed, source code review under a protective order. A patent whose infringement can only be proven through discovery carries more pre-suit risk than one whose infringement shows up in a teardown or a user manual.
A patent with strong claims and high market relevance can still be a poor assertion candidate if nobody can show the feature is in the product.
Stage 5: Patent Life
Remaining term affects value in two directions. A patent near expiry gives little bargaining power over future sales, and after expiry an injunction is no longer available. Past damages survive, though. Under 35 U.S.C. § 286, a patent owner can recover for infringement committed up to six years before filing suit, so a recently expired patent read on by a high-revenue product can still be worth asserting.
Prioritising the Portfolio: The Tier Matrix
Once each patent is scored, plotting claim strength against commercial value sorts the portfolio into four tiers.
- Tier 1, strong claims and high commercial value: prioritise for detailed analysis, licensing, and enforcement.
- Tier 2, strong claims with a limited market: keep and monitor, since the market can shift.
- Tier 3, weak claims and low commercial value: candidates for non-renewal or sale.
- Tier 4, high commercial value with weaker claims or thin evidence: review further. Continuation practice or additional evidence gathering can move some of these into Tier 1.
Weightings should follow the business goal. A portfolio being readied for sale is scored differently from one being prepared for an assertion campaign.
What Litigation Readiness Requires After Triage
A Tier 1 rating marks a patent as worth the next round of work. Before it is ready to assert, it usually still needs:
- Claim charts that map every claim element to evidence of use in the accused product.
- A validity check through a prior art search, since the usual first response from a defendant is an invalidity challenge.
- Evidence of use preserved in a form an expert can defend under cross-examination.
- An early damages view, to confirm the case justifies its cost.
Most of the elapsed time sits here. By Lumenci’s estimate, a standard high-medium-low triage takes attorneys one to three months, and building the collateral for litigation funding or case filing adds three to four more.
Challenges in Patent Portfolio Triage
- Portfolio size: thousands of patents across jurisdictions, with continuations and foreign counterparts that have to be grouped into families before scoring.
- Hidden evidence: features inside proprietary systems resist pre-suit infringement analysis.
- Moving technology: a patent that mapped onto current products five years ago may map onto nothing today, so triage has to be repeated.
- Split expertise: engineers, patent attorneys, and business teams weigh different criteria, and the framework has to reconcile them.
Where AI Fits in Patent Portfolio Assessment
AI patent portfolio analysis tools shorten the first pass considerably. They classify patents by technology, group families, find semantically similar prior art, and rank assets against defined criteria in hours rather than weeks. Our AI use cases in IP guide covers these applications in more detail.
The limits sit at the same stages that are hard for people. A model can flag a claim as broad, but reading it against the prosecution history to the standard a court expects takes a patent professional. A model can estimate that a product likely practises a feature, and confirming it takes testing. AI output makes a strong starting ranking, and the patents it places in Tier 1 still need expert review before anyone relies on them.
Why Lumenci for Patent Portfolio Triage
Lumenci has run patent analysis, infringement reviews, validity work, and litigation diligence for more than 200 clients across over 100,000 patents.
- Triage tied to evidence: our engineers check whether infringement can actually be shown, through product testing or reverse engineering, before a patent is ranked as assertable.
- No handoff after triage: Tier 1 patents move straight into claim charts, prior art searches, and damages support with the same team.
- Built for monetization decisions: our patent monetization practice uses the same triage output to scope licensing campaigns.
- AI-first screening at scale: iLumOS, Lumenci’s expert-powered AI platform, runs the first high-medium-low pass on large portfolios in minutes, and Lumenci’s experts take the shortlisted patents forward.
Talk to Lumenci about triaging your patent portfolio.
Conclusion
Most of the value in a patent portfolio sits in a small share of its patents. Triage is how an IP team finds that share before the budget for claim charts, prior art searches, and expert time is spent.
The five stages give that search a repeatable structure. Of the five, evidence availability is the one that most often separates a patent that looks strong on paper from one that can be asserted, so it is worth checking first.
Table of Contents
Frequently Asked Questions
What is patent portfolio triage?
It is a structured first pass that ranks every patent in a portfolio by technology relevance, claim strength, market potential, evidence availability, and remaining life. The result is a tiered list showing which patents deserve detailed review.
How is patent portfolio evaluation different from patent portfolio analysis?
Triage-level evaluation sorts the whole portfolio quickly using a few criteria. Full patent portfolio analysis is the detailed legal and technical review of the patents that triage selects.
What makes a patent litigation-ready?
Claim charts mapping every claim element to evidence of use, a validity check against prior art, evidence an expert can defend, and a damages estimate that justifies the cost of the case.
Why does evidence availability affect a patent's value?
Infringement has to be shown element by element. If the patented feature is hidden inside firmware or a server, proving it before suit may be impossible, which makes the patent a riskier assertion candidate.
Can an expired patent still be asserted?
Yes, for past infringement. Under 35 U.S.C. § 286, damages can be recovered for infringement up to six years before the complaint is filed, though an injunction is no longer available.
Can AI perform a patent portfolio assessment?
AI can run the first ranking pass on a large portfolio quickly. Claim construction, infringement evidence, and the final decision on litigation readiness still need patent professionals.
